|
|
Post by awesomo on May 16, 2018 13:11:32 GMT -5
Fantastic, any hard hitting questions?
|
|
|
|
Post by centralcoastinvestor on May 16, 2018 13:18:13 GMT -5
1. Concern about meeting revenue forcast?
2. Why do refills appear low?
3. How do we go back and get the people who tried Afrezza and stopped?
4. How do we spread the word about Afrezza?
|
|
|
|
Post by centralcoastinvestor on May 16, 2018 13:19:48 GMT -5
Dr. Kendall did a great job! Meeting just ended.
|
|
|
|
Post by MnkdWASmyRtrmntPlan on May 16, 2018 13:19:50 GMT -5
1. Concern about meeting revenue forcast? 2. Why do refills appear low? 3. How do we go back and get the people who tried Afrezza and stopped? 4. How do we spread the word about Afrezza? Great questions. What were the answers?  Oh, and btw, thanks for being there. Did anyone record it? |
|
|
|
Post by kc on May 16, 2018 13:33:38 GMT -5
Remember last year when the annual meeting was cut short and very little questions were taken. This meeting is the exact opposite. They are taking every question. More information and direction. That is good. Indicates a positive future |
|
|
|
Post by joeypotsandpans on May 16, 2018 13:51:25 GMT -5
One huge takeaway today that stood out to me were the key folks/players that followed Dr. Kendall from LLY...it's like we got LeBron along with the top 3 picks in the lottery!! Think key personnel with one in particular having been a key player responsible for Trulicity  |
|
|
|
Post by dreamboatcruise on May 16, 2018 13:57:46 GMT -5
Did everything on the agenda pass?
|
|
|
|
Post by madog365 on May 16, 2018 14:08:08 GMT -5
Did anyone record it, would like a listen.
|
|
|
|
Post by Clement on May 16, 2018 14:13:50 GMT -5
One huge takeaway today that stood out to me were the key folks/players that followed Dr. Kendall from LLY...it's like we got LeBron along with the top 3 picks in the lottery!! Think key personnel with one in particular having been a key player responsible for Trulicity Sorry, I missed this info if it was promulgated previously. Please tell us who are these three key folks who followed D Kendall from LLY. |
|
|
|
Post by kc on May 16, 2018 14:19:05 GMT -5
It was not published in the past but I am sure you always bring some folks with you. They are probably not in SR. MGMT rolls.
|
|
|
|
Post by dreamboatcruise on May 16, 2018 14:28:26 GMT -5
It was not published in the past but I am sure you always bring some folks with you. They are probably not in SR. MGMT rolls. Though the lead person on Trulicity I would think would be a Director level position... though different industries do use different hierarchy naming for management. |
|
|
|
Post by tingtongtung on May 16, 2018 14:32:24 GMT -5
Plan started with live video then audio, but now no updates from attendees? Did MNKD make you guys sign an NDA or something?
|
|
|
|
Post by kc on May 16, 2018 14:36:29 GMT -5
Plan started with live video then audio, but now no updates from attendees? Did MNKD make you guys sign an NDA or something? Have patience Grasshopper......It takes Patience to get Patients...... |
|
|
|
Post by lakers on May 16, 2018 14:57:05 GMT -5
Heidi Soto 3rd degree connection3rd Area Business Manager at Mannkind Corporation MannKind Corporation University of Southern California Greater Los Angeles Area Area Business Manager Company NameMannKind Corporation Dates EmployedFeb 2017 – Present Employment Duration1 yr 4 mos LocationBeverly Hills, California MannKind Corporation (NASDAQ and TASE: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. The company dates back to February 1991, when it was incorporated as Pharmaceutical Discovery Corporation (PDC) in Elmsford, New York. Our Technosphere® formulation technology was developed at PDC shortly after its formation. In the mid-1990s, Alfred Mann – at the time, the CEO of MiniMed Inc. – started working with PDC through a collaborative research effort and eventually became a significant shareholder. In 2001, the company merged with two other companies owned by Alfred Mann (CTL Immunotherapies Corp. and Allecure Corp.) and the surviving company changed its name to MannKind Corporation. As a result of this merger, we relocated the corporate headquarters to Valencia, California while focusing the East coast operations – by this time, located in Danbury, Connecticut – on improving the Technosphere® technology and developing our innovative line of delivery devices. Our Danbury location now houses a state-of-the-art manufacturing facility, where we manufacture Afrezza® (insulin human) inhalation powder, our first FDA-approved product. We are currently commercializing Afrezza in the United States, where it is available by prescription from pharmacies nationwide. Insulet Corporation Territory Manager Company NameInsulet Corporation Dates EmployedMay 2014 – Feb 2017 Employment Duration2 yrs 10 mos LocationGreater Los Angeles Area Responsible and accountable for consistently achieving sales objectives for the OmniPod Tubeless Insulin Pump System and ensuring these sales are profitable and within the guidelines of Insulet Corporation's defined sales and marketing practices. This includes also responsability for the development, management and growth of the healthcare professional recommendation to achieve sales and market share growth. Other key strategies include; expand business and brand loyalty within strategic accounts consisting of private practice, large diabetes clinics, hospital teaching institutions, and other major medical centers. Calling on customers to raise their level of awareness and increase the demand of the Insulet Corporation product line within the defined geographic territory. And correlating any professional contact needed within the above mentioned accounts with the operational, quality or customer service teams of Insulet Corporation. Eli Lilly and Company Senior Specialty Sales Representative, Diabetes & Endocrine Business Unit Company NameEli Lilly and Company Dates EmployedNov 2008 – Apr 2014 Employment Duration5 yrs 6 mos LocationGreater Los Angeles Area Responsible for developing relationships with all practicing endocrinologists and pediatric endocrinologists who are prescribers/influencers for diabetes and growth hormone disorders. This includes selling the diabetes portfolio (Humalog, Tradjenta, Jentadueto & Humatrope) in key hospital accounts: including interactions with attending endocrinologists, endocrine fellows, diabetes educators, chief internal medicine residents, chief family practice residents, and residents involved in endocrine rotations. * Lilly is the 5th largest pharmaceutical company in the country and the 10th largest pharmaceutical company in the world and has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. |
|
|
|
Post by bradleysbest on May 16, 2018 15:01:58 GMT -5
Super meeting where Dr K said he has found “veins of gold” in the data. Lots of good stuff happening with more to follow...
|
|
